201106 sharl and
TRANSCRIPT
-
8/2/2019 201106 Sharl And
1/4
research
Eleanor Sharland
Brett Montgomery
Raquel Granell
Folate is a water soluble B vitamin that
must be obtained in the diet or through
supplementation. For more than 50 years
it has been known that folate plays an
integral role in embryonic development.1
Periconceptional folic acid in doses
of at least 0.36 mg has been shown to
prevent approximately 72% of neural tubedefects,2,3 and therefore a daily dose of 0.4
mg is widely recommended for all women
at average risk from at least 1 month
preconception to 12 weeks pregnancy.4
Despite this, many Australian women
do not have sufficient folate intake in
pregnancy,5 thus mandatory folic acid
fortification of flour was introduced in
Australia in September 2009.6
The Generation 1 Cohort Std,7 pblished in 2009,
fond that the se of folic acid in late pregnanc
was associated with an increased risk of childhood
asthma. This was widel reported in the poplar
media, both in Astralia8 and overseas,9 leading
to concern abot the safet of folic acid in
late pregnanc. Man women take pregnanc
mltivitamins throghot pregnanc to achieve the
recommended intake of microntrients.10,11 As all
sch mltivitamins seem to inclde folic acid, their
se in late pregnanc wold present a dilemma if
folic acid were nsafe.
There is a plasible explanation for theassociation between folate intake and childhood
asthma. A laborator std in mice showed that
maternal exposre to a high methl donor diet,
which inclded folic acid, increased the severit
of inherited allergic airwa disease in offspring
throgh increased DNA methlation. This
predisposition appeared to be partiall transmitted
into sbseqent generations.12 However, findings
in animal models are not necessaril applicable to
hmans. Folic acid, which is the snthetic form of
the B vitamin, is a potentiall more potent methl
donor than natrall occrring folate and so ma
have different effects.7
Method
We condcted a narrative review of stdies
that investigate the association betweenmaternal dietar folate intake and/or folic acid
spplementation exposre and childhood asthma
or wheeze. We considered performing a meta-
analsis, bt decided this was inappropriate de
to heterogeneit of poplations stdied, exposre
measrements, and otcome measre reporting.
The first athor (ES) searched MEDLINE (Ovid and
PbMed) and CinAHL, sing the strateg (Folic
Acid OR Folate) AND pregnanc AND (asthma
OR respirator health), as well as (Folate OR
Folic Acid) AND late pregnanc. Frther citation
searches were ndertaken sing Web of Science.
The second athor (BM) independentl searched
PbMed sing the strateg (asthma OR wheeze
OR respirator) AND (folate OR folic) AND
pregnanc. We identified for relevant stdies,
all of which were observational cohort stdies.
Results
The main reslts from the different stdies
inclded in this review are smmarised in Table 1
Norwegian Mother and Child study
Hberg et al reported the Norwegian Mother
and Child Cohort Std that involved 32 077
children.13 This std measred maternal se of
folic acid spplements in earl and late pregnanc
and child lower respirator tract infections
and wheeze p to the age of 18 months. Data
were collected sing qestionnaires that were
completed b participating mothers at 17 weeks
and 30 weeks gestation as well as 6 months and
Folic acid in pregnancyIs there a linkwith childhood asthma or wheeze?
Background
Folic acid supplementation has an
established role in early pregnancy
for preventing neural tube defects.
However, there is controversy over a
possible link between late pregnancy
folic acid supplementation and
childhood asthma.
Objective
To review the evidence exploring the
association between maternal folate
exposure in pregnancy and childhood
asthma or wheeze.
Results
Four relevant observational studies
were identified. Two found statistically
significant associations between
childhood asthma and late (but not
early) pregnancy maternal folic acid
exposure. Another found a statisticallysignificant association between
childhood wheeze and early (but not
late) pregnancy maternal folic acid
exposure. A fourth study found little
association between maternal dietary
folate in pregnancy and infantile
wheeze.
Discussion
The currently available evidence
regarding an association between
folate in pregnancy and childhood
asthma or wheeze is conflicting.We offer suggestions for discussing
the potential risk with patients and
recommend further research on this
subject be conducted.
Keywords: folic acid; pregnancy; dietary
supplements; asthma
Reprinted from AuSTRALIAN FAMILy PHySICIAN VOL. 40, NO. 6, JuNE 2011 42
-
8/2/2019 201106 Sharl And
2/4
Folic acid in pregnancy is there a link with childhood asthma or wheeze?research
be noted that the relative r isks were expressed
per 1 mg/da dose of folate, whereas the
recommended dose for low risk women is 400 g/
da.6 This means that the increase in childhood
asthma risk for women on a tpical dose of folic
acid wold be mch smaller than these relative
risks impl.
Osaka Maternal and Child HealthStudy
A recent Japanese std14 involving 763 mother
and child pairs from the Osaka Maternal and
Child Health Std measred dietar intake
of B vitamins, inclding folate, and examined
associations with childhood atop inclding
wheeze and eczema as defined b responses to a
standardised maternal qestionnaire.
Folate intake was qantified sing a detailed
dietar qestionnaire, and mothers were thenfollowed p with a srve at 29 months and
1624 months postpartm. Folate intake was
divided into qartiles of amont consmed
(qartile medians: Q1=206.8 g/da; Q=255.1 g/
da; Q3=291.2 g/da; Q4=370.6 g/da), and
there were no data on timing in pregnanc. Even
in the highest qartile, intake was still below the
World Health Organization recommended dail
intake of 400 g/da.4 The std athors did not
inclde spplemental folic acid intake as this was
ncommon among the cohort (
-
8/2/2019 201106 Sharl And
3/4
researchFolic acid in pregnancy is there a link with childhood asthma or wheeze?
sggested to be netral or beneficial for a
nmber of other pregnanc otcomes inclding
gestational hpertension, pre-eclampsia, birth
weight, nerodevelopment, preterm birth,
placenta praevia1 and paediatric malignanc.17
The vast majorit of this evidence comes
from observational stdies, as there are few
randomised controlled trials of folic acid
spplementation in late pregnanc.
Conclusion
The crrent available evidence of an association
between late pregnanc folate intake and
childhood asthma or wheeze is conflicting. The
Norwegian std sggested a risk for wheeze
from earl, bt not late pregnanc folic acid
intake. In contrast, the Astralian and English
stdies sggested a risk for asthma from late,
bt not earl pregnanc folic acid intake. TheJapanese std fond no significant risk of
wheeze with dietar folate, bt did not std folic
acid spplementation. We are naware of an
other relevant research.
We feel that an association between
childhood asthma and late pregnanc folic
acid spplementation at standard doses is
possible. However, given the evidence at
present is drawn from cohort stdies, it has
limitations. A randomised controlled trial of
Limitations of the studies
As the inclded articles were all cohort stdies,
a shared limitation is that, despite attempting
to adjst for plasible measrable confonders,
some confonding factors ma exist. Several of the
stdies did not adjst for paternal atop, asthma
and smoking.7,13,15 Some confonders ma not be
easil measred. For example, we speclate that
a health conscios mother might be more likel
to take folic acid, attend a doctor for concerns
regarding child respirator health (increasing the
chance of a diagnosis), and emphasise childhood
hgiene, a ptative risk factor for asthma.16 Neither
the Norwegian nor the ALSPAC stdies qantified
folic acid spplement intake beond a es/no
measre, and the Norwegian std did not measre
dietar folate intake. The Japanese std ma
have been nderpowered, and it did not measre
spplemental folic acid intake. The for stdiesmeasred respirator otcomes at different ages,
and ascertained otcomes differentl, making
direct comparison difficlt. In addition, children
with infantile wheeze do not necessaril develop
asthma. The reslts from the ALSPAC are post hoc,
and therefore shold be interpreted with cation.
Folate in late pregnancy in context
Althogh otside the scope of this review,
folic acid intake in late pregnanc has been
between folate metabolism genotpe and allerg.
(The athors of this ALSPAC sb-std did not aim
to std associations between maternal folate
intake and childhood asthma, bt as we noted
that data had been collected on these factors, the
ALSPAC std athors were approached for more
information.)
The collected data inclded maternal dietar
folate intake (g/da) at 32 weeks of pregnanc,
as well as folic acid spplementation (es/no)
at 18 and 32 weeks. Childhood asthma was
measred at 7.5 ears of age and defined as
maternal recall of phsician diagnosis of asthma
together with wheeze within the previos
12 months. Analsis of these data ields the
previosl npblished reslts presented in
Table 2. Logistic regression models were sed
to evalate the association between childrens
asthma and maternal dietar/spplementalfolate intake. Reslts were adjsted for gender,
maternal histor of asthma or allerg, exposre
to prenatal and postnatal maternal smoking and
mothers edcation. There was no association
between childrens asthma and maternal dietar
folate intake at 32 weeks. However, there was
moderate evidence of a positive association
between childrens asthma and maternal
spplemental folic acid intake at 32 weeks (adj
OR 1.24, 95% CI: 1.021.51, p=0.03).15
Table 2. Association between asthma and maternal dietary folate intake or folic acid supplementation in the ALSPAC cohort15
OR (95% CI), pvalue for
childrens asthma at 7.5 years
Number of children
with asthma/no asthma
Mean (SD) for
asthmatics
Mean (SD) for
nonasthmatics
Crude Adjusted
Continuous variables
A) Maternal dietary folate intake
at 32 weeks (per 100 g/day)
599/5503 254.9 (68.2) 255.7 (7.07) 0.98 (0.87, 1.11)
p=0.77
0.97 (0.86, 1.10)
p=0.65
Binary variables
B) Maternal supplemental folic
acid intake at 18 weeks gestation
599/5491 NA NA 1.20 (0.94, 1.55)
p=0.14
1.17 (0.91, 1.51)
p=0.22
B) Maternal supplemental folic
acid intake at 32 weeks gestation
599/5503 NA NA 1.25 (1.04, 1.49)
p=0.02
1.25 (1.04, 1.49)
p=0.02
C) Maternal supplemental folic
acid intake at 32 weeks gestation
598/5480 NA NA 1.26 (1.05, 1.50)
p=0.01
1.24 (1.02, 1.51)
p=0.03
A) Adjusted for gender, maternal history of asthma or allergy, maternal supplemental folic acid at 32 weeks gestation, exposure to prenatal and
postnatal maternal smoking and mothers education
B) Adjusted for gender, maternal history of asthma or allergy, maternal dietary folate intake at 32 weeks gestation, exposure to prenatal and
postnatal maternal smoking and mothers education
C) Adjusted as in B, but also adjusted for maternal supplemental folic acid intake at 18 weeks gestation
Reprinted from AuSTRALIAN FAMILy PHySICIAN VOL. 40, NO. 6, JuNE 2011 423
-
8/2/2019 201106 Sharl And
4/4
Folic acid in pregnancy is there a link with childhood asthma or wheeze?research
between mother and child MTHFR C677T polmor-phisms, dietar folate intake and childhood atop ina poplation-based, longitdinal birth cohort. ClinExp Allerg 2008;38:3208.
16. Bran-Fahrlnder C, Riedler J, Herz u, et al.Environmental exposre to endotoxin and its rela-tion to asthma in school-age children. New Engl JMed 2002;347:86977.
17. Goh yI, Koren G. Folic acid in pregnanc and fetalotcomes. J Obstet Gnaecol 2008;28:313.
18. Hpponen E, Bocher BJ. Avoidance of vitamin Ddeficienc in pregnanc in the united Kingdom: thecase for a nified approach in national polic. Br JNtr 2010;104:30914.
19. National Health and Medical Research Concil.Iodine spplementation for pregnant and breast-feeding women. Canberra: NHMRC, 2010. Availableat www.nhmrc.gov.a/pblications/snopses/new45_sn.htm.
20. Astralian Centre for Asthma Monitoring. Asthmain Astralia 2008. AIHW Asthma Series No. 3.Canberra: AIHW, 2008.
AcknowledgmentsWe thank Jon Emer and John Henderson for
helpfl comments on this article. Eleanor Sharland
is gratefl to General Practice Edcation and
Training for fnding her academic registrar post at
the universit of Western Astralia, dring which
mch of this research was ndertaken.
References1. Tamra T, Picciano MF. Folate and hman reprodc-
tion. Am J Clin Ntr 2006;83:9931016.
2. Lmle J, Watson L, Watson M, et al.Periconceptional spplementation with folate and/or mltivitamins for preventing neral tbe defects.Cochrane Database Sst Rev 2001;3:CD001056.Available at www.mrw.interscience.wile.com/
cochrane/clssrev/articles/CD001056/frame.html.3. Czeizel AE, Ddas I, Metneki J. Pregnanc
otcomes in a randomized controlled trial of peri-conceptional mltivitamin spplementation final
report. Arch Gnecol Obstet 1994;255:1319.4. Lincetto O. Prevention of neral tbe defects.
Department of Making Pregnanc Safer, WorldHealth Organization, 2007. Available at www.who.int/reprodctivehealth/pblications/maternal_peri-
natal_health/neral_tbe_defects.pdf.5. Hre A, yong A, Smith R, et al. Diet and pregnanc
stats in Astralian women. Pblic Health Ntr2009;12:85361.
6. Food Standards Astralia New Zealand.Mandator folic acid fortification in Astralia,2009. Available at www.foodstandards.gov.a/scienceandedcation/factsheets/factsheets2009/
mandatorfolicacidfo4389.cfm.7. Whitrow MJ, Moore VM, Rmbold AR, et al. Effect
of spplemental folic acid in pregnanc on child-hood asthma: a prospective birth cohort std. Am JEpidemiol 2009;170:148693.
8. AAP. Folic acid in pregnanc linked to asthma.
Sdne Morning Herald, 5 November 2009.Available at www.smh.com.a/lifestle/wellbeing/folic-acid-in-pregnanc-linked-to-asthma-20091105-
hvs.html.9. Campbell D. Researchers link asthma risk to folic
acid dring pregnanc. Gardian, 4 November 2009.Available at www.gardian.co.k/science/2009/
nov/04/asthma-folic-acid-pregnanc-research.10. Forster DA, Wills G, Denning A, et al. The se of
folic acid and other vitamins before and dringpregnanc in a grop of women in Melborne,Astralia. Midwifer 2009;25:13446.
11. Maats FH, Crowther CA. Patterns of vitamin,mineral and herbal spplement se prior to anddring pregnanc. Ast N Z J Obstet Gnaecol2002;42:4946.
12. Hollingsworth J, Maroka S, Boon K, et al. In terospplementation with methl donors enhancesallergic airwa disease in mice. J Clin Invest2008;118:34629.
13. Haberg SE, London SJ, Stigm H, et al. Folic acid
spplements in pregnanc and earl childhood res-pirator health. Arch Dis Child 2009;94:1804.
14. Miake y, Sasaki S, Tanaka K, et al. Maternal Bvitamin intake dring pregnanc and wheeze and
eczema in Japanese infants aged 1624 months:The Osaka Maternal and Child Health Std. PediatrAllerg Immnol 2011;22(1 Pt 1):6974.
15. Granell R, Heron J, Lewis S, et al. The association
folic acid spplementation in late pregnanc
wold offer more reliable evidence. Considering
the range of possible benefits and risks from
folate spplementation, and the fact that sch
spplementation is commonl sed, sch a std
cold be considered bt wold face challenges of
adeqate power and ethical acceptabilit.
Implications for practice
We will contine to recommend
periconceptional and earl pregnanc folic acid
spplementation for the prevention of neral
tbe defects. Given the possible association
with asthma, we wold not recommend
spplements containing onl folic acid in late
pregnanc. However, given the ncertaint of
this risk, and the possible benefits of other
microntrients (which are otside the scope
of this article bt reviewed elsewhere18,19
) wewold not dissade a pregnant woman from
taking a standard pregnanc mltivitamin.
We wold remind women that respirator risks
from late pregnanc folic acid are nproven, bt
that even if the are real, the absolte increase
in risk to an individal child wold be fairl
small. Hpotheticall, if the relative risk increase
of asthma from standard dose late pregnanc
folic acid was 1020% (consistent with the
Astralian and English stdies), and assming
an Astralian childhood asthma prevalence of
20%,20 a pregnant woman taking folic acid in
late pregnanc wold increase her childs risk
of asthma b 24%. Coching the statistics in
these terms ma help patients make an informed
decision.
AuthorsEleanor Sharland MBBS(Hons), FRACGP, is a
former academic registrar, Discipline of General
Practice, School of Primar, Aboriginal and Rral
Health Care, universit of Western Astralia,
Perth, Western Astralia. [email protected]
Brett David Montgomer MBBS, DCH, FRACGP,is Associate Professor, Discipline of General
Practice, School of Primar, Aboriginal and Rral
Health Care, universit of Western Astralia,
Perth, Western Astralia
Raqel Granell BSc(Valencia), MSc(Bristol),
PhD(Bristol), is Research Fellow, School of Social
and Commnit Medicine, universit of Bristol,
Oakfield, united Kingdom.
Conflict of interest: none declared.
424 Reprinted from AuSTRALIAN FAMILy PHySICIAN VOL. 40, NO. 6, JuNE 2011